Literature DB >> 9831247

Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.

K M Catron1, J R Brickwood, C Shang, Y Li, M F Shannon, T P Parks.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) is up-regulated on numerous cell types in response to inflammatory cytokines. Tumor necrosis factor-alpha (TNF-alpha) activates the ICAM-1 promoter through a variant nuclear factor-kappaB (NF-kappaB) site at -187/-178 bp upstream of the transcription start site. In this investigation, we provide biochemical and functional evidence that an adjacent CCAAT/enhancer binding protein (C/EBP) site and this variant NF-kappaB site define a composite element for activation of the ICAM-1 promoter in certain cell lines. We detected an endogenous TNF-alpha-inducible DNA-protein complex in nuclear extracts from A549, HeLa, and EVC304 cells that contained both RelA and C/EBPbeta but not other family members. Complex formation required intact C/EBP and NF-kappaB sites and was absolutely dependent on translocation of RelA into the nucleus. Complex formation and cooperative binding were also demonstrated using recombinant proteins, and as above, both binding sites were necessary. Interestingly, the RelA/C/EBPbeta complex was not detected in either Jurkat or Raji cells, indicating cell type specificity. Functional studies with various reporter gene constructs revealed that both binding sites were required for maximal activation of the ICAM-1 promoter in response to TNF-alpha and for synergistic activation by RelA and C/EBPbeta. This is the first detailed analysis of how RelA and C/EBPbeta function to regulate ICAM-1 expression, and this study has important implications for how this gene is activated in specific cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831247

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

1.  Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.

Authors:  Alexey M Chumakov; Agnes Silla; Elizabeth A Williamson; H Phillip Koeffler
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine.

Authors:  H Wang; X Qu; I G De Plaen; W Hsueh
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

3.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3.

Authors:  Alok Agrawal; Hyunjoo Cha-Molstad; David Samols; Irving Kushner
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

5.  Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Authors:  Matthias Altmeyer; Michael O Hottiger
Journal:  Aging (Albany NY)       Date:  2009-05-20       Impact factor: 5.682

6.  Regulation of bacteria-induced intercellular adhesion molecule-1 by CCAAT/enhancer binding proteins.

Authors:  Lori J Manzel; Cecilia L Chin; Mark A Behlke; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

7.  Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.

Authors:  Bin Yan; Huai Li; Xinping Yang; Jiaofang Shao; Minyoung Jang; Daogang Guan; Sige Zou; Carter Van Waes; Zhong Chen; Ming Zhan
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.